SBHMY
Price
$20.16
Change
+$0.66 (+3.38%)
Updated
Aug 27 closing price
Capitalization
17.76B
VIVS
Price
$1.87
Change
+$0.03 (+1.63%)
Updated
Aug 28 closing price
Capitalization
4.86M
Interact to see
Advertisement

SBHMY vs VIVS

Header iconSBHMY vs VIVS Comparison
Open Charts SBHMY vs VIVSBanner chart's image
Sino Biopharmaceutical
Price$20.16
Change+$0.66 (+3.38%)
Volume$264
Capitalization17.76B
VivoSim Lab
Price$1.87
Change+$0.03 (+1.63%)
Volume$10.35K
Capitalization4.86M
SBHMY vs VIVS Comparison Chart in %
Loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SBHMY vs. VIVS commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Hold and VIVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (SBHMY: $20.16 vs. VIVS: $1.87)
Brand notoriety: SBHMY and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 45% vs. VIVS: 20%
Market capitalization -- SBHMY: $17.76B vs. VIVS: $4.86M
SBHMY [@Biotechnology] is valued at $17.76B. VIVS’s [@Biotechnology] market capitalization is $4.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 1 green FA rating(s).

  • SBHMY’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 1 green, 4 red.
According to our system of comparison, both SBHMY and VIVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBHMY’s TA Score shows that 1 TA indicator(s) are bullish while VIVS’s TA Score has 6 bullish TA indicator(s).

  • SBHMY’s TA Score: 1 bullish, 3 bearish.
  • VIVS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VIVS is a better buy in the short-term than SBHMY.

Price Growth

SBHMY (@Biotechnology) experienced а +3.38% price change this week, while VIVS (@Biotechnology) price change was -5.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($17.8B) has a higher market cap than VIVS($4.86M). VIVS YTD gains are higher at: 306.610 vs. SBHMY (147.190). SBHMY has higher annual earnings (EBITDA): 6.89B vs. VIVS (-1.72M). SBHMY has higher revenues than VIVS: SBHMY (28.9B) vs VIVS (142K).
SBHMYVIVSSBHMY / VIVS
Capitalization17.8B4.86M366,104%
EBITDA6.89B-1.72M-401,748%
Gain YTD147.190306.61048%
P/E Ratio33.34N/A-
Revenue28.9B142K20,352,113%
Total CashN/A9.06M-
Total DebtN/A822K-
FUNDAMENTALS RATINGS
SBHMY vs VIVS: Fundamental Ratings
SBHMY
VIVS
OUTLOOK RATING
1..100
4981
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
8893
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3536
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
4585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (3) in the null industry is in the same range as VIVS (16) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to VIVS’s over the last 12 months.

SBHMY's Profit vs Risk Rating (88) in the null industry is in the same range as VIVS (93) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to VIVS’s over the last 12 months.

SBHMY's SMR Rating (100) in the null industry is in the same range as VIVS (100) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to VIVS’s over the last 12 months.

SBHMY's Price Growth Rating (35) in the null industry is in the same range as VIVS (36) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to VIVS’s over the last 12 months.

SBHMY's P/E Growth Rating (100) in the null industry is in the same range as VIVS (100) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to VIVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBHMYVIVS
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
37%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
34%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
41%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FEAM3.680.26
+7.60%
5E Advanced Materials Inc.
HE12.890.28
+2.22%
Hawaiian Electric Industries
CIB49.800.25
+0.50%
Grupo Cibest SA
JXG1.02N/A
-0.18%
JX Luxventure Group Inc
EBF18.41-0.10
-0.54%
Ennis

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
+0.17%
SYBX - SBHMY
34%
Loosely correlated
-0.68%
BTAI - SBHMY
32%
Poorly correlated
+3.54%
CLRPF - SBHMY
24%
Poorly correlated
-6.67%
VIVS - SBHMY
20%
Poorly correlated
+1.63%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with LVTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
+1.63%
LVTX - VIVS
42%
Loosely correlated
N/A
GLTO - VIVS
38%
Loosely correlated
-4.17%
ORMP - VIVS
37%
Loosely correlated
-0.45%
ACET - VIVS
27%
Poorly correlated
+0.40%
KRRO - VIVS
26%
Poorly correlated
+9.68%
More